IBT — International Biotechnology Trust Balance Sheet
0.000.00%
Last trade - 00:00FinancialsBalancedSmall Cap
- £310.10m
- £324.72m
- £6.07m
Annual balance sheet for International Biotechnology Trust, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.
2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 1.56 | 0 | — | 10.4 | 15 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.898 | 13.4 | 2.93 | 0.208 | 0.115 |
| Prepaid Expenses | |||||
| Total Current Assets | 2.5 | 13.5 | 2.97 | 10.6 | 15.1 |
| Long Term Investments | |||||
| Total Assets | 348 | 327 | 305 | 308 | 284 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 24.1 | 42 | 34.6 | 25.9 | 34.6 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 24.1 | 42 | 34.6 | 25.9 | 34.6 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 324 | 285 | 270 | 282 | 249 |
| Total Liabilities & Shareholders' Equity | 348 | 327 | 305 | 308 | 284 |
| Total Common Shares Outstanding |